Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Biguanide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biguanide SCHEMBL28206103 | 0.87 | CYP1A2 (0.42) | MAPTTDP1CYP1A2CYP2C19TSHR | |
| Biguanide SCHEMBL18255803 | 0.84 | MAPK1 (0.31) | NOS1 | |
| Biguanide SCHEMBL8039 | 0.84 | — | — | |
| Biguanide SCHEMBL28774142 | 0.83 | NOS3 (0.36) | TDP1CYP1A2CYP2C19TSHRNOS1 | |
| Biguanide SCHEMBL15969880 | 0.82 | CA12 (0.56) | MAPTTDP1CYP1A2CYP2C19TSHR | |
| Biguanide SCHEMBL5489883 | 0.81 | — | — | |
| Biguanide SCHEMBL4221594 | 0.81 | — | — | |
| Biguanide SCHEMBL10881314 | 0.81 | — | — | |
| Biguanide SCHEMBL1428352 | 0.81 | — | — | |
| Biguanide SCHEMBL4217126 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114561046-A | Guanidine-based hyaluronic acid type antibacterial hydrogel and preparation method and application thereof | 江南大学 | 2022-05-31 | — | — | CN | disclosed |
| US-5789138-A | Optical recording medium and method of producing the same | RICOH COMPANY, LTD. (JP) | 1998-08-04 | — | — | US | disclosed |